In this study, we investigated the potential role and mechanism of the RNA‐binding protein MSI2 in NSCLC progression and reported that ELK4 transcriptionally promoted MSI2 expression and regulated the progression of NSCLC through the TGF‐β/SMAD3 pathway. This evidence concerns the gene SMAD3 and non-small cell lung carcinoma.